ProMetic Life Sciences and NantPharma have together formed an affiliate company, NantPro BioSciences, to develop and commercialize a plasma-derived biopharmaceutical product for the US market. The new US based company has entered into ...
Tags: affiliate company, plasma-derived biopharmaceutical product
Prosetta Antiviral has entered into a multi-year collaboration with Bristol-Myers Squibb Company to further discover and develop select drug candidates representing new, novel classes of antiviral drugs. The collaboration will focus on ...
Tags: lect drug candidates, antiviral drugs, viral infections
Cancer Therapeutics has announced the validation and performance of CTx-294886 in combination with Avastin in a preclinical model of basal breast cancer. The CTx-0294886, a potent small molecule inhibitor of Focal Adhesion Kinase (FAK) ...
Tags: cancer therapeutics, CTx-294886, basal breast cancer, FAK inhibitor
Aegis Therapeutics has received a US patent covering Parathyroid Hormone (PTH) and PTH analogue compositions suitable for metered nasal spray, oral, and injectable delivery. The stabilized PTH formulations incorporate Aegis' ...
Tags: Aegis Therapeutics, PTH formulations, Intravail and ProTek excipients
Aegis Therapeutics has received US patent covering pharmaceutical composition of octreotide. The octreotide formulations incorporate Aegis' Intravail/ProTek excipients suitable for all routes of administration including oral, buccal, ...
Tags: Octreotide Formulations, Aegis Therapeutics, polysorbate surfactants
The European Commission has cleared an oral anticoagulant, Eliquis, developed by Bristol-Myers Squibb (BMS) and Pfizer. Eliquis 5mg, trade name of apixaban in Europe, is indicated as a twice-daily drug for preventing strokes and systemic ...
Tags: BMS-Pfizer Oral Anticoagulant, oral anticoagulant, Eliquis, apixaban
Celgene International Sàrl Abraxane, an albumin-bound form of paclitaxel, has demonstrated statistically significant improvementin overall survival for advanced pancreatic cancer patients in Phase III study. The Metastatic ...
AvidBiotics has received new Small Business Innovation Research (SBIR) grant from the National Institute of Allergic and Infectious Diseases of the National Institutes of Health to further develop targetable bactericidal proteins to kill ...
Capstone Therapeutics and LipimetiX have formed LipimetiX Development , a joint venture (JV), to develop drugs that are used to treat indications of lowering blood cholesterol levels. The JV will develop a family of Apo E mimetic peptides ...
Tags: Apolipoprotein E, lipoprotein metabolism, Capstone Therapeutics
Synthetic Biologics has enterd into second worldwide exclusive channel collaboration with Intrexon to address unmet medical needs of infectious diseases. Synthetic Biologics leverages Intrexon's suite of proprietary technologies for the ...
Tags: Synthetic Biologics, infectious diseases, medical needs
Clinical-stage biopharmaceutical company Omeros Corporation said that it has discovered the proteins that activate the alternative pathway of the complement system as part of the company's mannan-binding lectin associated serine protease-2 ...
Tags: complement system, protease-2(MASP-2)program, pro-inflammatory protein
Pernix Therapeutics Holdings has launched Omeclamox-Pak, a ten-day therapy, to eradicate Helicobacter pylori (H. pylori) in adult patients. Omeclamox-Pak is composed of omeprazole delayed-release capsules (20mg), clarithromycin tablets ...
Tags: Omeclamox-Pak, H.pylori, ten-day therapy
GlaxoSmithKline (GSK) has entered into a drug discovery alliance with Yale to design a potential new class of medicines that degrade disease-causing proteins. Under the collaboration, GSK integrates its expertise in medicinal chemistry ...
Tags: Yale University, Drug Discovery Alliance, protein-degrading drug
Gerber Products, an operating unit of Nestle group, has introduced Gerber Good Start Soothe formula with probiotic L reuteri. The formula is designed to reduce excessive crying and colic in healthy infants. The Soothe variety contains ...
Tags: Gerber Products, Infant Formula
Balance Bar, a US-based developer of nutrition energy bars, has launched its new Balance Bar Dark line, which will be available in three flavors. The three flavors in the new range includes Dark Chocolate Crunch, Dark Chocolate Coconut ...
Tags: nutrition energy bars, Dark Chocolate Crunch, Dark Chocolate Coconut